Profilo
Jaak Minten formerly worked at Celyad Oncology SA, as Director-Clinical Affairs, Medtronic GmbH, as Director-Clinical, Anethon NV, as Pre-Clinical Development Director, and Katholieke Universiteit Leuven, as Principal in 1985.
Dr. Minten received his graduate degree and doctorate degree from Katholieke Universiteit Leuven.
Precedenti posizioni note di Jaak Minten
| Società | Posizione | Fine |
|---|---|---|
Anethon NV
 Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | Corporate Officer/Principal | 07/08/2013 |
| Katholieke Universiteit Leuven | Corporate Officer/Principal | 01/01/1985 |
| CELYAD ONCOLOGY SA | Corporate Officer/Principal | - |
Medtronic GmbH
 Medtronic GmbH Medical SpecialtiesHealth Technology Part of Medtronic Plc, Medtronic GmbH is a German company that offers women's health treatments and therapies. The private company is based in Meerbusch, Germany and was founded in 1970. The company has recently received FDA approval for their Minimed™ 780g system, which provides real-time insulin adjustments and corrections. The CEOs are Sylvia Theis and Michael Clark Genau. Medtronic is committed to transforming healthcare by working with new partners in new ways, and their innovations have already changed the lives of more than 65 million people worldwide last year. | Corporate Officer/Principal | - |
Formazione di Jaak Minten
| Katholieke Universiteit Leuven | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CELYAD ONCOLOGY SA | Health Technology |
| Aziende private | 2 |
|---|---|
Medtronic GmbH
Medtronic GmbH Medical SpecialtiesHealth Technology Part of Medtronic Plc, Medtronic GmbH is a German company that offers women's health treatments and therapies. The private company is based in Meerbusch, Germany and was founded in 1970. The company has recently received FDA approval for their Minimed™ 780g system, which provides real-time insulin adjustments and corrections. The CEOs are Sylvia Theis and Michael Clark Genau. Medtronic is committed to transforming healthcare by working with new partners in new ways, and their innovations have already changed the lives of more than 65 million people worldwide last year. | Health Technology |
Anethon NV
Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | Health Technology |
- Borsa valori
- Insiders
- Jaak Minten
